SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-167897
Filing Date
2024-06-25
Accepted
2024-06-25 16:28:31
Documents
12
Effectiveness Date
2024-06-25

Document Format Files

Seq Description Document Type Size
1 S-8 d843931ds8.htm S-8 41614
2 EX-5.1 d843931dex51.htm EX-5.1 9156
3 EX-23.1 d843931dex231.htm EX-23.1 2500
4 EX-99.2 d843931dex992.htm EX-99.2 36596
5 EX-99.3 d843931dex993.htm EX-99.3 30677
6 EX-99.4 d843931dex994.htm EX-99.4 38756
7 EX-99.5 d843931dex995.htm EX-99.5 39029
8 EX-99.6 d843931dex996.htm EX-99.6 35046
9 EX-99.7 d843931dex997.htm EX-99.7 43044
10 EX-FILING FEES d843931dexfilingfees.htm EX-FILING FEES 16018
11 GRAPHIC g843931g0621001329567.jpg GRAPHIC 2658
12 GRAPHIC g843931g93m77.jpg GRAPHIC 1773
  Complete submission text file 0001193125-24-167897.txt   299974
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280463 | Film No.: 241069320
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)